Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...
A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...
Heavy-ion therapy, one of the most advanced radiotherapy techniques, has proven to be more effective than conventional X-rays ...
During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.
Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...
Lupron and other LHRH agonists are forms of hormone-blocking therapy. For people with prostate cancer, hormone-blocking therapy aims to reduce testosterone levels in the body. Male hormones ...
Objectives The administration of androgen deprivation therapy (ADT) to patients with metastatic prostate cancer might be associated with some adverse effects such as anaemia; however, few studies have ...
The treatment of advanced gastric cancer patients with poor performance status after ... an ongoing clinical trial of ADC combined with PD-1 inhibitor and radiotherapy sequential GM-CSF and IL-2 in ...
There are lots of ways to treat thyroid cancer. The treatment you get will depend on the type and stage of the cancer. It also depends on your age, general health, and other things that are unique ...
No writing assistance was utilized in the production of this manuscript. Sequential therapy refers to treatment with drug regimens administered one after another. Combination therapy refers to ...
drugs that block cancer blood vessel growth and PARP inhibitors. Immunotherapy treatments include checkpoint inhibitors, vaccines, cytokines and CAR T-cell therapy. Monoclonal antibodies (mAbs) may be ...
The trial used residual DNA from cancer cells that can find its way into a patient's bloodstream to identify when patients were beginning to resist the standard endocrine treatment, and were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results